Gilead Sciences Inc (GILD):企業の財務・戦略的SWOT分析

◆英語タイトル:Gilead Sciences Inc (GILD) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1668
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:60
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,125見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,375見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Gilead Sciences Inc (GILD) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Gilead Sciences Inc (Gilead) is a research-based biopharmaceutical company. It focuses on the discovery, development and commercialization of medicines for the treatment of cardiovascular, hematological and respiratory diseases, inflammation, liver diseases, cancer and human immunodeficiency virus (HIV) infection. Gilead develops products that offer improved methods of delivery, enhanced resistance profile, minimized side effects and greater efficiency. The company sells its products through subsidiaries and distributors in Europe, the Americas, Asia-Pacific, the Middle East and Africa. The company has partnerships with universities, medical research institutions and global pharmaceutical leaders to develop new drugs. Gilead is headquartered in Foster City, California, the US.

Gilead Sciences Inc Key Recent Developments

Apr 21,2020 Gilead, Kite and oNKo-innate announce research collaboration to discover cancer immunotherapies focused on natural killer (NK) cells
Apr 16,2020 Former Gilead Sciences Head of Clinical Trial Disclosure and Data Transparency Joins MMS and TrialAssure as Director of Global Transparency Strategy and Compliance
Apr 08,2020 Gilead announces $20 million philanthropic fund to support nonprofit organizations impacted by the COVID-19 crisis
Apr 07,2020 Gilead signs drug discovery deal with Second Genome

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Gilead Sciences Inc – Key Facts
Gilead Sciences Inc – Key Employees
Gilead Sciences Inc – Key Employee Biographies
Gilead Sciences Inc – Major Products and Services
Gilead Sciences Inc – History
Gilead Sciences Inc – Company Statement
Gilead Sciences Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Gilead Sciences Inc – Business Description
Geographical Segment: Europe
Performance
Geographical Segment: Other International
Performance
Geographical Segment: US
Performance
R&D Overview
Gilead Sciences Inc – Corporate Strategy
Gilead Sciences Inc – SWOT Analysis
SWOT Analysis – Overview
Gilead Sciences Inc – Strengths
Gilead Sciences Inc – Weaknesses
Gilead Sciences Inc – Opportunities
Gilead Sciences Inc – Threats
Gilead Sciences Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Gilead Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Gilead Sciences Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Gilead Sciences Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 21, 2020: Gilead, Kite and oNKo-innate announce research collaboration to discover cancer immunotherapies focused on natural killer (NK) cells
Apr 16, 2020: Former Gilead Sciences Head of Clinical Trial Disclosure and Data Transparency Joins MMS and TrialAssure as Director of Global Transparency Strategy and Compliance
Apr 08, 2020: Gilead announces $20 million philanthropic fund to support nonprofit organizations impacted by the COVID-19 crisis
Apr 07, 2020: Gilead signs drug discovery deal with Second Genome
Apr 03, 2020: Kite licences Teneobio’s multiple myeloma targeting antibodies
Mar 27, 2020: Novartis partners with life sciences companies to fight Covid-19
Mar 26, 2020: Mylan and Gilead waive exclusivity for potential Covid-19 therapies
Mar 26, 2020: Novartis and life sciences companies commit expertise and assets to the fight against COVID-19 pandemic alongside Bill & Melinda Gates Foundation
Mar 23, 2020: Feinstein Institutes announces partnerships for Covid-19 trials
Mar 23, 2020: Gilead Sciences Statement on Ensuring Continued Supply of HIV Medicine Amid Coronavirus Outbreak
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Gilead Sciences Inc, Key Facts
Gilead Sciences Inc, Key Employees
Gilead Sciences Inc, Key Employee Biographies
Gilead Sciences Inc, Major Products and Services
Gilead Sciences Inc, History
Gilead Sciences Inc, Other Locations
Gilead Sciences Inc, Subsidiaries
Gilead Sciences Inc, Joint Venture
Gilead Sciences Inc, Key Competitors
Gilead Sciences Inc, Ratios based on current share price
Gilead Sciences Inc, Annual Ratios
Gilead Sciences Inc, Annual Ratios (Cont...1)
Gilead Sciences Inc, Annual Ratios (Cont...2)
Gilead Sciences Inc, Interim Ratios
Gilead Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Gilead Sciences Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Gilead Sciences Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Gilead Sciences Inc, Performance Chart (2015 - 2019)
Gilead Sciences Inc, Ratio Charts
Gilead Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Gilead Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Gilead Sciences Inc (GILD):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Santos Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Santos Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Santos Ltd (Santos) is an independent oil and natural gas company. Its activities include onshore, offshore and liquefied natural gas (LNG) projects. The company has exploration and production acreage in …
  • ADT LLC:戦略・SWOT・企業財務分析
    ADT LLC - Strategy, SWOT and Corporate Finance Report Summary ADT LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • ResApp Health Ltd (RAP):製薬・医療:M&Aディール及び事業提携情報
    Summary ResApp Health Ltd (ResApp) formerly, Narhex Life Sciences Limited is a digital health company that develops smartphone applications for the diagnosis and management of respiratory disease. It's digital healthcare solutions assist doctors and patients to diagnose and manage respiratory diseas …
  • Stellar Resources Limited:企業の戦略・SWOT・財務情報
    Stellar Resources Limited - Strategy, SWOT and Corporate Finance Report Summary Stellar Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Nimbus Therapeutics LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Nimbus Therapeutics LLC (Nimbus Therapeutics), formerly Nimbus Discovery LLC, is a biotechnology company that develops medicines for critical diseases such as metabolic disease, cancer, and immune-inflammatory disorders. The company harnesses its expertise in deep computational chemistry to …
  • Gould Paper Corp:企業の戦略的SWOT分析
    Gould Paper Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • PRA Health Sciences Inc (PRAH):製薬・医療:M&Aディール及び事業提携情報
    Summary PRA Health Sciences Inc (PRA) is a contract research organization (CRO) which provides clinical development services. The company offers services such as phase I-IV study management, and embedded and functional outsourcing services. It offers solutions in bioanalytical laboratories, biometri …
  • Cloud Live Technology Group Co. Ltd.
    Cloud Live Technology Group Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Cloud Live Technology Group Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • NetEnt AB (NET B):企業の財務・戦略的SWOT分析
    Summary NetEnt AB (NetEnt), formerly Net Entertainment NE AB, is a gaming solution provider. The company offers netent live, pooled jackpots, branded games, casinomodule, back office, touch, live casino and extend. It provides services such as business intelligence, regulated markets, iGaming media …
  • InterOil Exploration & Production ASA (IOX):石油・ガス:M&Aディール及び事業提携情報
    Summary InterOil Exploration & Production ASA (InterOil Exploration & Production) is an oil and gas company that provides petroleum exploration services. The company acquires, explores, develops and operates oil and natural gas properties, among others. It operates as an active license partner in se …
  • Refresco Gerber B.V.:企業の戦略・SWOT・財務情報
    Refresco Gerber B.V. - Strategy, SWOT and Corporate Finance Report Summary Refresco Gerber B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Ultragenyx Pharmaceutical Inc (RARE):企業の財務・戦略的SWOT分析
    Ultragenyx Pharmaceutical Inc (RARE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Fauji Fertilizer Bin Qasim Ltd (FFBL):企業の財務・戦略的SWOT分析
    Fauji Fertilizer Bin Qasim Ltd (FFBL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • M3, Inc. (2413):企業の財務・戦略的SWOT分析
    M3, Inc. (2413) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Regal Hotels International Holdings Ltd:企業の戦略・SWOT・財務情報
    Regal Hotels International Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Regal Hotels International Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • KeyCorp:企業の戦略・SWOT・財務情報
    KeyCorp - Strategy, SWOT and Corporate Finance Report Summary KeyCorp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Caixa Economica Federal:企業の戦略・SWOT・財務情報
    Caixa Economica Federal - Strategy, SWOT and Corporate Finance Report Summary Caixa Economica Federal - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Kura Oncology Inc (KURA):企業の財務・戦略的SWOT分析
    Summary Kura Oncology Inc (Kura Oncology) is a clinical-stage biopharmaceutical company that discovers and develops therapeutics for the treatment of solid tumors and blood cancers. The company’s lead drug candidate Tipifarnib, an inhibitor of farnesyl transferase, an oral investigational drug candi …
  • Hitachi, Ltd.:企業のM&A・事業提携・投資動向
    Hitachi, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Hitachi, Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Boursorama SA:企業の戦略・SWOT・財務情報
    Boursorama SA - Strategy, SWOT and Corporate Finance Report Summary Boursorama SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆